BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products
News Nov 15, 2017
To date, there are 122 published articles altogether in this collection. This large collection is an earned honor for BOC Sciences after the past fifteen years of endeavors and fully demonstrates that products offered by BOC Sciences have received enough recognition among scholars and researchers, contributing to the advance of scientific explorations.
Published in Scientific Reports, ACS Applied Materials & Interfaces, Cells as well as dozens of other world-renowned professional scientific magazines and journals, many valuable findings are made concerning a wide range of research topics such as chemical synthesis, discovery of new and novel drugs to treat cancers, high blood pressure, heart disease, etc.
For example, celastrol purchased from BOC Sciences (Shirley, NY) was used as supplemental experimental procedures reagents in the research of obesity treatment. The relevant findings was compiled in an article titled Treatment of Obesity with Celastrol, which was published in Cell.
Founded in 2005 as a company specializing in small-molecule inhibitors, BOC Sciences has now expanded to offer a comprehensive range of chemical products and related solutions in the pharmaceutical industry including bioconjugation, biochemistry, biochemical and cellular analysis, compound synthesis and other clinical studies. “This means that customers now can find nearly whatever they want or need from BOC Sciences, which is the goal we are always striving for,” stated the Manager of Public Relations at BOC Sciences.
As always, BOC Sciences will continue to offer premium chemicals and meanwhile assist its customers with a complete suite of CRO services spanning the entire molecule development.
New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living SystemsNews
Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.READ MORE
Protein Target Identified That Could Prevent StrokesNews
Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. The researchers believe medications that activate GPR68 could one day be useful to treat medical conditions, including ischemic stroke.READ MORE
How Environmental Pollutants and Genetics Work Together in Rheumatoid ArthritisNews
It is well known that individuals with a particular version of human leukocyte antigen have an increased risk for rheumatoid arthritis, but there has been growing interest in the role of environmental pollutants. In a new mouse study, researchers probed the relationship between the two.READ MORE
Comments | 0 ADD COMMENT
2nd International Conference and Exhibition on Nanomedicine and Drug Delivery
May 21 - May 23, 2018